azetidyl-2-carboxylic acid has been researched along with Stroke in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, K; Deguchi, K; Hishikawa, N; Ikeda, Y; Kono, S; Kurata, T; Liu, W; Omote, Y; Yamashita, T | 1 |
Abe, K; Deguchi, K; Kamiya, T; Lukic-Panin, V; Sehara, Y; Yamashita, T; Zhang, H | 1 |
Araki, S; Hirooka, Y; Kishi, T; Koga, Y; Konno, S; Sunagawa, K | 1 |
Hirano, T; Okamoto, S; Shiraishi, S; Tomiguchi, S; Uchino, M; Watanabe, M | 1 |
1 trial(s) available for azetidyl-2-carboxylic acid and Stroke
Article | Year |
---|---|
Azelnidipine, a long-acting calcium channel blocker, could control hypertension without decreasing cerebral blood flow in post-ischemic stroke patients. A 123I-IMP SPECT follow-up study.
Topics: Aged; Azetidinecarboxylic Acid; Blood Pressure; Brain Ischemia; Calcium Channel Blockers; Cerebral Infarction; Cerebrovascular Circulation; Dihydropyridines; Female; Follow-Up Studies; Functional Laterality; Heart Rate; Humans; Hypertension; Image Processing, Computer-Assisted; Iofetamine; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Stroke; Tomography, Emission-Computed, Single-Photon | 2010 |
3 other study(ies) available for azetidyl-2-carboxylic acid and Stroke
Article | Year |
---|---|
Synergistic neuroprotective effects of combined treatment with olmesartan plus azelnidipine in stroke-prone spontaneously hypertensive rats.
Topics: Age Factors; Animals; Azetidinecarboxylic Acid; Blood Pressure; Brain Injuries; Chemokine CCL2; Collagen Type IV; Dihydropyridines; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation; Heart Rate; Imidazoles; Laser-Doppler Flowmetry; Male; Matrix Metalloproteinase 9; Motor Activity; Oxidative Stress; Rats; Rats, Inbred SHR; Stroke; Tetrazoles | 2014 |
Therapeutic strategy for ischemic stroke.
Topics: Animals; Azetidinecarboxylic Acid; Biliverdine; Brain Ischemia; Dihydropyridines; Free Radical Scavengers; Granulocyte Colony-Stimulating Factor; Neuroprotective Agents; Rats; Stem Cells; Stroke; Tissue Scaffolds | 2009 |
Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Antioxidants; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Heart Rate; Hydralazine; Hypertension; Male; Medulla Oblongata; NADPH Oxidases; Norepinephrine; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke; Superoxide Dismutase; Sympathetic Nervous System; Thiobarbituric Acid Reactive Substances | 2008 |